Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence
Dermatologic Therapy · 2022-12 · 35 (12)
DOI: 10.1111/dth.15903 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatologic Therapy, online erschienen am 21.10.2022. Verfasst von Bruna Bravo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bravo's Clinic, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Skin Aging, Dermal Fillers, Cosmeceuticals, Botulinum Toxins, Type A. Die Arbeit wurde bisher 173-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cosmetic Active International, L'Oréal.
Abstract (Originalsprache)
Skin aging goes beyond a chronological process and also results from extrinsic factors referred to as the exposome. Hyaluronic acid (HA) is an important component of the extracellular matrix, with loss starting at 25 years old. While many studies of HA concern topical use, few literature reviews only address the use of topical HA in dermatology. This review describes the different characteristics of HA‐containing cosmeceuticals, with a focus on skin aging and the impact of exposome factors on HA synthesis and degradation. A review was performed using the terms HA, hyaluronan, topical, dermatology, cosmetic, aging treatment, exposome, and cosmeceuticals. Results are also presented from a recent randomized controlled trial (RCT), which investigated the additional benefit of using a HA epidermic filler (HA‐filler serum) combined with Botulinum toxin type A (BoNTA) to treat signs of skin aging. Subjects were randomized to two groups: HA‐filler serum starting 24 h after the BoNTA injection then twice daily for 24 weeks, or the control group, which received BoNTA. HA is a key ingredient used in cosmeceuticals for its hydration/antiaging properties (hygroscopic, rheological, and viscoelastic). Several clinical studies indicate that HA is both well tolerated and effective, adjuvant to both post‐surgical and facial rejuvenation procedures. In the RCT, one of few studies to combine BoNTA and HA with a 6‐month follow‐up, the HA‐filler serum lengthened the duration of BoNTA's effect in reducing wrinkles. Numerous studies support HA‐based cosmeceuticals as a noninvasive, effective solution for improving skin hydration and rejuvenation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bravo's Clinic, Rio de Janeiro, Brazil.
- Scientific Expertise, Cosmetic Active, L'Oréal Brasil, Rio de Janeiro, Brazil.
- Cosmetic Active International, L'Oréal, Paris, France.
ORCID-Profile: Bruna Bravo, Priscila Correia, José Euzébio Gonçalves Junior, Beatriz Sant'Anna, Delphine Kerob
Förderung
- Cosmetic Active International, L'Oréal
Zitieren
APA
Bravo, B., Correia, P., Gonçalves Junior, J. E., Sant'Anna, B., & Kerob, D. (2022). Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy, 35(12). https://doi.org/10.1111/dth.15903
Vancouver
Bravo B, Correia P, Gonçalves Junior JE, Sant'Anna B, Kerob D. Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy. 2022;35(12). doi:10.1111/dth.15903
BibTeX
@article{Bravo2022,
author = {Bravo, Bruna and Correia, Priscila and Gonçalves Junior, José Euzébio and Sant'Anna, Beatriz and Kerob, Delphine},
title = {Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence},
journal = {Dermatologic Therapy},
year = {2022},
volume = {35},
number = {12},
doi = {10.1111/dth.15903}
}
EUVIMED